Current Treatment landscape in Multiple Sclerosis

Created using ChatSlide

This overview of the MS treatment landscape highlights the importance of defining MS phenotypes and prioritizing relapse control and disability prevention. It contrasts various treatment strategies, emphasizing the use of MRI and NEDA for monitoring responses while balancing efficacy and risks. Emerging directions include tracking BTK inhibitors and remyelination research, advocating for personalized treatment approaches, and the necessity of continuous monitoring for optimal patient outcomes.